PTJ
IMCR icon

Paul Tudor Jones’s Immunocore IMCR Stock Holding History

Paul Tudor Jones’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,231
Closed -$719K – 3942
2025
Q4 		$772K Buy
22,231
+1,092
+5% +$38.5K ﹤0.01% 2458
2025
Q3 		$768K Hold
21,139
– – ﹤0.01% 2443
2025
Q2 		$663K Sell
21,139
-33,354
-61% -$1.04M ﹤0.01% 2405
2025
Q1 		$1.62M Buy
+54,493
New +$1.63M 0.01% 1488

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Paul Tudor Jones's IMCR Position: Q1 2026 in Review

Paul Tudor Jones sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 22,231 shares — an estimated $719K sold.

Paul Tudor Jones first reported a position in IMCR in Q1 2025 and held it in 4 quarters. The position peaked at $1.62M in Q1 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Paul Tudor Jones reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 22,231 Immunocore shares in Q1 2026, an estimated $719K.
  • Paul Tudor Jones first reported a position in Immunocore in Q1 2025 and held it in 4 quarters.
  • Paul Tudor Jones's Immunocore position peaked at $1.62M in Q1 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.